IMVT - Immunovant - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

IMVT is currently covered by 11 analysts with an average price target of $47. This is a potential upside of $15.23 (47.94%) from yesterday's end of day stock price of $31.77.

Immunovant's activity chart (see below) currently has 181 price targets and 178 ratings on display. The stock rating distribution of IMVT is 59.09% BUY and 40.91% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 58.81% of the time, taking 206 days on average.

Highest price target for IMVT is $62, Lowest price target is $32, average price target is $47.

Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 10-Nov-2026. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 9 are a HOLD (40.91%), 13 are a BUY (59.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Jan-2026

$33

$1.23 (3.87%)

$30

12 days ago
(10-Nov-2026)

8/10 (80%)

$-2.71 (-7.59%)

239

Buy Since 24-Jul-2023

$47

$15.23 (47.94%)

$45

12 days ago
(10-Nov-2026)

8/13 (61.54%)

$11.29 (31.62%)

365

Buy Since 20-Feb-2024

$50

$18.23 (57.38%)

$35

3 months 18 days ago
(04-Aug-2026)

4/7 (57.14%)

$10.64 (27.03%)

207

Buy Since 25-Apr-2023

$61

$29.23 (92.01%)

$58

4 months 23 days ago
(30-Jun-2026)

2/8 (25%)

$22.47 (58.32%)

100

Buy Since 23-May-2023

$62

$30.23 (95.15%)

$44

5 months 27 days ago
(26-May-2026)

6/11 (54.55%)

$28.17 (83.27%)

217

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant) average time for price targets to be met?

On average it took 206 days for the stock forecasts to be reached, with an average price target met ratio of 58.81%.

Which analyst most recently updated their price target on IMVT (Immunovant)?

Danielle Brill

Which analyst has the most public recommendations on IMVT (Immunovant)?

Danielle Brill works at TRUIST and has 10 price targets and 8 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant)?

Yatin Suneja with the highest potential upside of $30.23

Which analyst is the currently most reserved on IMVT (Immunovant)?

Brian Skorney with the lowest potential downside of -$21.77
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?